Features | Partner Sites | Information | LinkXpress
Sign In
Schiller
Fluke Biomedical
Ampronix

Noncompliant Coronary Balloon Helps Navigate Tortuous Anatomy

By HospiMedica International staff writers
Posted on 16 Jun 2014
Image: The NC Euphora noncompliant balloon dilatation catheter with tapered tip (Photo courtesy Medtronic).
Image: The NC Euphora noncompliant balloon dilatation catheter with tapered tip (Photo courtesy Medtronic).
A new noncompliant coronary balloon provides superior deliverability and controlled growth in challenging angioplasty procedures.

The NC Euphora Noncompliant Balloon Dilatation Catheter offers enhanced deliverability through tight lesions via proprietary PowerTrac technology, thus requiring less force application to provide tracking through tortuous anatomy. An optimized tapered tip design and low lesion entry profile improve flexibility and allow for reliable stent re-cross when traversing long, challenging lesions, so that the balloon does not catch on a strut when passing through a deployed stent.

The balloon is made of strong, durable, and flexible Low Inflation Growth, High Track (LIGHT) material that provides high pressure capability, enabling the NC Euphora to expand consistently within the stent area at a rated burst pressure—the maximum pressure that the balloon can be repeatedly inflated in a safe manner—of up to 20 atmospheres without bursting. Significantly low radial growth reduces unwanted vessel expansion and longitudinal growth beyond the stent length, minimizing damage to the surrounding healthy artery. The NC Euphora Noncompliant Balloon Dilatation Catheter is a product of Medtronic (Minneapolis, MN, USA).

“NC Euphora expands our interventional portfolio with another clinically-relevant tool that was developed with both interventionalists and cath lab teams' needs in mind,” said Jason Weidman, vice president and general manager of Medtronic's coronary business. “With the addition of a premium noncompliant balloon, our interventional customers have a complement to the other innovative Medtronic offerings throughout the entire procedure for their most difficult and challenging cases.”

“When using a noncompliant balloon, deliverability and re-cross are important characteristics, especially when faced with challenging coronary anatomy,” said consultant interventional cardiologist Robert Gerber, MD, PhD, of Eastbourne District General Hospital East Sussex Healthcare NHS Trust, and preclinical researcher for the NC Euphora balloon. “The NC Euphora balloon was designed to meet these demands and provide reliable performance with no tradeoffs in the moment that we need it most.”

Related Links:

Medtronic
Eastbourne District General Hospital East Sussex Healthcare NHS Trust



Cincinnati Sub-Zero
ECR
ACEM

Channels

Critical Care

view channel
Image: An example of the new feeding tube connector (Spikeright Plus by Nestle) (Photo courtesy of Nestle Nutrition).

New Feeding Tube Connectors Improve Patient Safety

New feeding tube connectors designed by an international standards process will greatly reduce the incidence of harmful, even fatal, misconnections. Developed by the Global Enteral Device Supplier Association... Read more

Women's Health

view channel

Contraceptive Pills Halve Size of Women’s Ovaries

A new study has found that birth control pills can reduce women’s ovaries upward of 50% in size, but the that the ovaries appear to return to normal after cessation. Researchers at Rigshospitalet (Copenhagen, Denmark) and Copenhagen University (Denmark) conducted a study involving 833 women, aged 19–46, of whom almost... Read more

Business

view channel
Image: The Baxter line of Xenium XPHPOLYNEPHRON synthetic fiber dialyzers (Photo courtesy of Baxter International).

Baxter to Expand Hemodialysis Manufacturing Capacity

Baxter International (Baxter, Deerfield, IL, USA) is planning expand its US manufacturing facility to help address the growing global demand for dialyzers, a critical component in hemodialysis therapy (HD).... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.